Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07183852
What this trial is testing

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 18
Testing effectiveness (Phase 2)Study completedNCT00450255
What this trial is testing

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+5 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00072163
What this trial is testing

Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma

Who this might be right for
Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
National Cancer Institute (NCI) 50
Very early researchWithdrawnNCT04223648
What this trial is testing

Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Yale University
Testing effectiveness (Phase 2)Study completedNCT00189332
What this trial is testing

Use of 852A in Metastatic Cutaneous Melanoma.

Who this might be right for
MelanomaUnresectable Metatstatic Cutaneous Melanoma
Pfizer 28
Not applicableWithdrawnNCT04941365
What this trial is testing

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

Who this might be right for
Metastatic MelanomaMetastatic Breast CancerAdvanced Renal Cell Carcinoma+3 more
Institut du Cancer de Montpellier - Val d'Aurelle
Testing effectiveness (Phase 2)Study completedNCT01319565
What this trial is testing

Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 102
Very early researchStudy completedNCT02013492
What this trial is testing

Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Male Breast CancerRecurrent MelanomaStage IV Breast Cancer+5 more
William Carson 1
Testing effectiveness (Phase 2)Study completedNCT02581930
What this trial is testing

Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma

Who this might be right for
Metastatic MelanomaRecurrent Cutaneous MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT03538314
What this trial is testing

UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Ultimovacs ASA 30
Testing effectiveness (Phase 2)WithdrawnNCT04060407
What this trial is testing

CD24Fc With Ipilimumab and Nivolumab to Decrease irAE (CINDI)

Who this might be right for
Metastatic Melanoma
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Testing effectiveness (Phase 2)WithdrawnNCT02061007
What this trial is testing

Biomarker Correlates of Hypoxia in Metastatic Melanoma

Who this might be right for
MelanomaSkin Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT01217411
What this trial is testing

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

Who this might be right for
Adult Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaHER2/Neu Negative+10 more
National Cancer Institute (NCI) 5
Not applicableNo Longer AvailableNCT04489433
What this trial is testing

Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02681549
What this trial is testing

Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
MelanomaNon-small Cell Lung CancerBrain Metastasis
Yale University 41
Large-scale testing (Phase 3)Active Not RecruitingNCT05352672
What this trial is testing

Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 1,546
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT03765229
What this trial is testing

An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma

Who this might be right for
Melanoma
UNC Lineberger Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00003346
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center 80
Early research (Phase 1)Study completedNCT03864042
What this trial is testing

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Melanoma
Pfizer 56
Next Page